TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 0 | 0 | 7,045 |
Financial expenses | 506 | 57 | 161 |
Earnings before taxes | -55,215 | -48,590 | -33,780 |
EBITDA | -54,755 | -48,549 | -33,844 |
Total assets | 48,246 | 55,397 | 33,686 |
Current assets | 41,734 | 54,474 | 31,726 |
Current liabilities | 11,410 | 9,659 | 9,798 |
Equity capital | 32,644 | 45,518 | 23,166 |
- share capital | 1,294 | 1,098 | 786 |
Employees (average) | 9 | 8 | 10 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 67.7% | 82.2% | 68.8% |
Turnover per employee | 0 | 0 | 704 |
Profit as a percentage of turnover | -479.5% | ||
Return on assets (ROA) | -113.4% | -87.6% | -99.8% |
Current ratio | 365.8% | 564.0% | 323.8% |
Return on equity (ROE) | -169.1% | -106.7% | -145.8% |
Change turnover | 0 | -6,558 | -1,781 |
Change turnover % | -100% | -20% | |
Chg. No. of employees | 1 | -2 | -2 |
Chg. No. of employees % | 13% | -20% | -17% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.